Transcriptional responses associated with sulfur mustard and thermal burns in porcine skin

Cutaneous and Ocular Toxicology

Volumn 27, Issue 3, 2008, Pages 135-160

  Rogers, James V ^a   McDougal, James N ^b   Price, Jennifer A ^a   Reid, Frances M ^a   Graham, John S ^c  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Microarray; Porcine; Skin; Sulfur mustard; Thermal injury

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MUSTARD GAS; RNA; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CHEMICAL BURN; CONTROLLED STUDY; EXCISION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; RNA HYBRIDIZATION; RNA ISOLATION; SIGNAL TRANSDUCTION; SKIN INJURY; SWINE; THERMAL EXPOSURE; TISSUE SECTION;

ANIMALS; BURNS; FEMALE; GENE EXPRESSION PROFILING; HOT TEMPERATURE; MUSTARD GAS; RNA; SKIN; SWINE; TRANSCRIPTION, GENETIC;

SUIDAE; SUS;

EID: 55749103704     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520802092054     Document Type: Article

References (101)

1. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001; 10:1793-1805.
2. Cole J, Tsou R, Wallace K, Gibran N, Isik F. Comparison of normal human skin gene expression using cDNA microarrays. Wound Repair Regen 2001; 9:77-85.
3. Curto EV, Lambert GW, Davis RL, Wilborn TW, Dooley TP. Biomarkers of human skin cells identified using DermArray DNA arrays and new bioinformatics methods. Biochem Biophys Res Commun 2002; 291:1052-1064.
4. McDougal JN, Garrett CM, Amato CM, Berberich SJ. Effects of brief cutaneous JP-8 jet fuel exposures on time course of gene expression in the epidermis. Toxicol Sci 2007; 95:495-510.
5. McDougal JN, Garrett CM. Gene expression and target tissue dose in the rat epidermis after brief JP-8 and JP-8 aromatic and aliphatic component exposures. Toxicol Sci 2007; 97:569-581.
6. Oestreicher JL, Walters IB, Kikuchi T, Gilleaudeau P, Surette J, Schwertschlag U, Dorner AJ, Krueger JG, Trepicchio WL. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 2001; 1:272-287.
7. Rogers JV, Garrett CM, McDougal JN. Gene expression in rat skin induced by irritating chemicals. J Biochem Mol Toxicol 2003; 17:123-137.
8. Rogers JV, Choi YW, Kiser RC, Babin MC, Casillas RP, Schlager JJ, Sabourin CL. Microarray analysis of gene expression in murine skin exposed to sulfur mustard. J Biochem Mol Toxicol 2004; 18:289-299.
9. Sesto A, Navarro M, Burslem F, Jorcano JL. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 2002; 99:2965-2970.
10. Smiley AK, Klingenberg JM, Aronow BJ, Boyce ST, Kitzmiller WJ, Supp DM. Microarray analysis of gene expression in cultured skin substitutes compared with native human skin. J Invest Dermatol 2005; 125:1286-1301.
11. Takao J, Ariizumi K, Dougherty II, Cruz PD Jr. Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiation. Photodermatol Photoimmunol Photomed 2002; 18:5-13.
12. Wang Z, Liu Y, Mori M, Kulesz-Martin M. Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates. Carcinogenesis 2002; 23:635-643.
13. Goldberg Z, Rocke DM, Schwietert C, Berglund SR, Santana A, Jones A, Lehmann J, Stern R, Lu R, Hartmann SC. Human in vivo dose-response to controlled, low-dose low linear energy transfer ionizing radiation exposure. Clin Cancer Res 2006; 12:3723-3729.
14. Dillman JF III, Hege AI, Phillips CS, Orzolek LD, Sylvester AJ, Bossone C, Henemyre-Harris C, Kiser RC, Choi YW, Schlager JJ, Sabourin CL. Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfide: gene expression profiles correlate with treatment efficacy and an established clinical endpoint. J Pharmacol Exp Ther 2006; 317:76-87.
15. Platteborze PL. Effects of sulfur mustard on transcription in human epidermal keratinocytes: analysis by mRNA differential display. J Appl Toxicol 2003; 23:249-254.
16. Sabourin CL, Petrali JP, Casillas RP. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J Biochem Mol Toxicol 2000; 14:291-302.
17. Sabourin CL, Danne MM, Buxton KL, Casillas RP, Schlager JJ. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 2002; 16:263-272.
18. Sabourin CL, Danne MM, Buxton KL, Rogers JV, Niemuth NA, Blank JA, Babin MC, Casillas RP. Modulation of sulfur mustard-induced inflammation and gene expression by olvanil in the hairless mouse vesicant model. J Cutan Ocular Toxicol 2003; 22:125-136.
19. Sabourin CL, Rogers JV, Stonerock MK, Niemuth NA, Kiser RC, Casbohm SL, Babin MC, Schlager JJ, Casillas RP. Alterations of gene expression in sulfur mustard-exposed skin topically-treated with vanilloids. J Cutan Ocular Toxicol 2004; 23:321-328.
20. Schlager JJ, Hart BW. Stress gene activity in HepG2 cells after sulfur mustard exposure. J Appl Toxicol 2000; 20:395-405.
21. Feezor RJ, Paddock HN, Baker HV, Varela JC, Barreda J, Moldawer LL, Schultz GS, Mozingo DW. Temporal patterns of gene expression in murine cutaneous burn wound healing. Physiol Genomics 2004; 16:341-348.
22. Spies M, Dasu MR, Svrakic N, Nesic O, Barrow RE, Perez-Polo JR, Herndon DN. Gene expression analysis in burn wounds of rats. Am J Physiol Regul Integr Comp Physiol 2002; 283:R918-R930.
23. Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol 1992; 44:640-645.
24. Hebda PA, Klingbeil CK, Abraham JA, Fiddes JC. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 1990; 95:626-631.
25. Montagna W, Yun JS. The skin of the domestic pig. J Invest Dermatol 1964; 42:11-21.
26. Smith KJ, Casillas R, Graham J, Skelton HG, Stemler F, Hackley BE Jr. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. J Dermatol Sci 1997; 14:126-135.
27. Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH Jr, Squibb KS. Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns 2002; 28:719-730.
28. Reid FM, Graham J, Niemuth NA, Singer AW, Janny SJ, Johnson JB. Sulfur mustard-induced skin burns in weanling swine evaluated clinically and histopathologically. J Appl Toxicol 2000; 20(Suppl 1):S153-S160.
29. Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH Jr, Squibb KS. Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res Technol 2002; 8:57-69.
30. Graham JS, Reid FM, Niemuth NA, Shumaker SM, Waugh JD. Effects of three anesthetic regimens on bioengineering methods conducted on ventral abdominal skin of weanling swine. J Cutan Ocular Toxicol 2004; 23:105-118.
31. Rice P, Brown RF, Lam DG, Chilcott RP, Bennett NJ. Dermabrasion - a novel concept in the surgical management of sulphur mustard injuries. Burns 2000; 26:34-40.
32. Graham JS, Reid FM, Smith JR, Stotts RR, Tucker ES, Shumaker SM, Niemuth NA, Janny SJ. A cutaneous full-thickness liquid sulfur mustard burn model in weanling swine: clinical pathology and urinary excretion of thiodiglycol. J Appl Toxicol 2000; 20(Suppl 1):S161-S172.
33. Graham JS, Stevenson RS, Mitcheltree LW, Simon M, Hamilton TA, Deckert RR, Lee RB. Improved wound healing of cutaneous sulfur mustard injuries in a weanling pig model. J Burns Wounds 2006; 5:e7.
34. Tsai S, Cassady JP, Freking BA, Nonneman DJ, Rohrer GA, Piedrahita JA. Annotation of the Affymetrix porcine genome microarray. Anim Genet 2006; 37:423-424.
35. Dasu MR, Hawkins HK, Barrow RE, Xue H, Herndon DN. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 2004; 202:476-485.
36. Paddock HN, Schultz GS, Baker HV, Varela JC, Beierle EA, Moldawer LL, Mozingo DW. Analysis of gene expression patterns in human postburn hypertrophic scars. J Burn Care Rehabil 2003; 24:371-377.
37. Tsou R, Cole JK, Nathens AB, Isik FF, Heimbach DM, Engrav LH, Gibran NS. Analysis of hypertrophic and normal scar gene expression with cDNA microarrays. J Burn Care Rehabil 2000; 21:541-550.
38. Wu J, Ma B, Yi S, Wang Z, He W, Luo G, Chen X, Wang X, Chen A, Barisoni D. Gene expression of early hypertrophic scar tissue screened by means of cDNA microarrays. J Trauma 2004; 57:1276-1286.
39. Graham JS, Chilcott RP, Rice P, Milner SM, Hurst CG, Maliner BI. Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J Burns Wounds 2005; 4:e1.
40. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007; 13:1359-1362.
41. Holcomb JB. The 2004 Fitts lecture: current perspective on combat casualty care. J Trauma 2005; 59:990-1002.
42. Starnes BW, Beekley AC, Sebesta JA, Andersen CA, Rush RM Jr. Extremity vascular injuries on the battlefield: tips for surgeons deploying to war. J Trauma 2006; 60:432-442.
43. Xiao-Wu W, Herndon DN, Spies M, Sanford AP, Wolf SE. Effects of delayed wound excision and grafting in severely burned children. Arch Surg 2002; 137:1049-1054.
44. Enoch S, Grey JE, Harding KG. ABC of wound healing. Non-surgical and drug treatments. BMJ 2006; 332:900-903.
45. DiPietro LA. Wound healing: the role of the macrophage and other immune cells. Shock 1995; 4:233-240.
46. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69:513-521.
47. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83:835-870.
48. Bhat S, Song YH, Lawyer C, Milner SM. Modulation of the complement system by human beta-defensin 2. J Burns Wounds 2007; 5:e10.
49. Suber F, Carroll MC, Moore FD Jr. Innate response to self-antigen significantly exacerbates burn wound depth. Proc Natl Acad Sci USA 2007; 104:3973-3977.
50. Asghar SS, Pasch MC. Therapeutic inhibition of the complement system. Y2K update. Front Biosci 2000; 5:E63-E81.
51. Makrides SC. Therapeutic inhibition of the complement system. Pharmacol Rev 1998; 50:59-87.
52. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 2000; 52:91-112.
53. Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, Nielsen BS, Christensen IJ, Craik CS, Werb Z, Dano K, Romer J. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 2006; 25:2686-2697.
54. Maquerlot F, Galiacy S, Malo M, Guignabert C, Lawrence DA, d'Ortho MP, Barlovatz-Meimon G. Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing. Am J Pathol 2006; 169:1624-1632.
55. Watanabe M, Yano W, Kondo S, Hattori Y, Yamada N, Yanai R, Nishida T. Upregulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest Ophthalmol Vis Sci 2003; 44:3332-3338.
56. Okumura N, Seki T, Ariga T. Cell surface-bound plasminogen regulates hepatocyte proliferation through a uPA-dependent mechanism. Biosci Biotechnol Biochem 2007; 71:1542-1549.
57. Yamaguchi Y, Yamada K, Suzuki T, Wu YP, Kita K, Takahashi S, Ichinose M, Suzuki N. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl, D-Arg8]-vasopressin (dDAVP). Am J Physiol Endocrinol Metab 2004; 287:E970-E976.
58. Borregaard N, Theilgaard-Monch K, Cowland JB, Stahle M, Sorensen OE. Neutrophils and keratinocytes in innate immunity - cooperative actions to provide antimicrobial defense at the right time and place. J Leukoc Biol 2005; 77:439-443.
59. van Buul JD, Hordijk PL. Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 2004; 24:824-833.
60. Gibran NS, Ferguson M, Heimbach DM, Isik FF. Monocyte chemoattractant protein-1 mRNA expression in the human burn wound. J Surg Res 1997; 70:1-6.
61. Swift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 2001; 117:1027-1035.
62. Weber KS, Nelson PJ, Grone HJ, Weber C. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 1999; 19:2085-2093.
63. Tsuruta J, Sugisaki K, Dannenberg AMJr, Yoshimura T, Abe Y, Mounts P. The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 1996; 20:293-318.
64. Goodman RB, Forstrom JW, Osborn SG, Chi EY, Martin TR. Identification of two neutrophil chemotactic peptides produced by porcine alveolar macrophages. J Biol Chem 1991; 266:8455-8463.
65. Schramm R, Liu Q, Thorlacius H. Expression and function of MIP-2 are reduced by dexamethasone treatment in vivo. Br J Pharmacol 2000; 131:328-334.
66. Wolpe SD, Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 1989; 3:2565-2573.
67. Ledger TN, Pinton P, Bourges D, Roumi P, Salmon H, Oswald IP. Development of a macroarray to specifically analyze immunological gene expression in swine. Clin Diagn Lab Immunol 2004; 11:691-698. s
68. Fang Y, Gong SJ, Xu YH, Hambly BD, Bao S. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice. Br J Dermatol 2007; 157:458-465.
69. Schaffner A, Rhyn P, Schoedon G, Schaer DJ. Regulated expression of platelet factor 4 in human monocytes-role of PARs as a quantitatively important monocyte activation pathway. J Leukoc Biol 2005; 78:202-209.
70. Frank S, Kampfer H, Wetzler C, Stallmeyer B, Pfeilschifter J. Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J 2000; 347(pt 1):265-273.
71. Yu G, Rux AH, Ma P, Bdeir K, Sachais BS. Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood 2005; 105:3545-3551.
72. Avniel S, Arik Z, Maly A, Sagie A, Basst HB, Yahana MD, Weiss ID, Pal B, Wald O, Ad-El D, Fujii N, Renzana-Seisdedos F, Jung S, Galun E, Gur E, Peled A. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 2006; 126:468-476.
73. Florin L, Maas-Szabowski N, Werner S, Szabowski A, Angel P. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci 2005; 118:1981-1989.
74. Peters T, Sindrilaru A, Hinz B, Hinrichs R, Menke A, Al-Azzeh EA, Holzwarth K, Oreshkova T, Wang H, Kess D, Walzog B, Sulyok S, Sunderkotter C, Friedrich W, Wlaschek M, Krieg T, Scharffetter-Kochanek K. Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J 2005; 24:3400-3410.
75. Edmondson SR, Thumiger SP, Werther GA, Wraight CJ. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 2003; 24:737-764.
76. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
77. Eming SA, Werner S, Bugnon P, Wickenhauser C, Siewe L, Utermohlen O, Davidson JM, Krieg T, Roers A. Accelerated wound closure in mice deficient for interleukin-10. Am J Pathol 2007; 170:188-202.
78. Moroguchi A, Ishimura K, Okano K, Wakabayashi H, Maeba T, Maeta H. Interleukin-10 suppresses proliferation and remodeling of extracellular matrix of cultured human skin fibroblasts. Eur Surg Res 2004; 36:39-44.
79. Alas S, Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 2001; 61:5137-5144.
80. Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ, Bondada S. Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol 2006; 79:1314-1327.
81. Cheon H, Rho YH, Choi SJ, Lee YH, Song GG, Sohn J, Won NH, Ji JD. Prostaglandin E2 augments IL-10 signaling and function. J Immunol 2006; 177:1092-1100.
82. Kalechman Y, Sredni B, Weinstein T, Freidkin I, Tobar A, Albeck M, Gafter U. Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101. J Am Soc Nephrol 2003; 14:620-630.
83. Mao JT, Roth MD, Serio KJ, Baratelli F, Zhu L, Holmes EC, Strieter RM, Dubinett SM. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers. Clin Cancer Res 2003; 9:5835-5841.
84. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8:240-246.
85. Hallman M, Ramet M, Ezekowitz RA. Toll-like receptors as sensors of pathogens. Pediatr Res 2001; 50:315-321.
86. Janssens S, Beyaert R. Role of toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003; 16:637-646.
87. Werling D, Jungi TW. TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 2003; 91:1-12.
88. Breslin JW, Wu MH, Guo M, Reynoso R, Yuan SY. Toll-like receptor 4 contributes to microvascular inflammation and barrier dysfunction in thermal injury. Shock 2008; 29:349-355.
89. McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2005; 125:1-8.
90. Badolato R. Leukocyte circulation: one-way or round-trip? Lessons from primary immunodeficiency patients. J Leukoc Biol 2004; 76:1-6.
91. Kellermann SA, Hudak S, Oldham ER, Liu YJ, McEvoy LM. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol 1999; 162:3859-3864.
92. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000; 103:757-768.
93. Babin MC, Ricketts K, Skvorak JP, Gazaway M, Mitcheltree LW, Casillas RP. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J Appl Toxicol 2000; 20(Suppl 1):S141-S144.
94. Casillas RP, Kiser RC, Truxall JA, Singer AW, Shumaker SM, Niemuth NA, Ricketts KM, Mitcheltree LW, Castrejon LR, Blank JA. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J Appl Toxicol 2000; 20(Suppl 1):S145-S151.
95. Wormser U, Brodsky B, Green BS, Rad-Yellin R, Nyska A. Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants. Arch Toxicol 1997; 71:165-170.
96. Lang CH, Silvis C, Nystrom G, Frost RA. Regulation of myostatin by glucocorticoids after thermal injury. FASEB J 2001; 15:1807-1809.
97. Khan A, Greenman J, Archibald SJ. Small molecule CXCR4 chemokine receptor antagonists: developing drug candidates. Curr Med Chem 2007; 14:2257-2277.
98. Tan L, Hatzirodos N, Wormald PJ. Effect of nerve growth factor and keratinocyte growth factor on wound healing of the sinus mucosa. Wound Repair Regen 2007.
99. Inoue K, Takahashi T, Uehara K, Shimuzu H, Ido K, Morimatsu H, Omori E, Katayama H, Akagi R, Morita K. Protective role of heme oxygenase 1 in the intestinal tissue injury In hemorrhagic shock in rats. Shock 2008; 29:252-261.
100. Yamada J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res 2003; 76:161-167.
101. Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T, Iizawa Y. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro- 4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol 2006; 69:1288-1295.